NL7011683A - - Google Patents

Info

Publication number
NL7011683A
NL7011683A NL7011683A NL7011683A NL7011683A NL 7011683 A NL7011683 A NL 7011683A NL 7011683 A NL7011683 A NL 7011683A NL 7011683 A NL7011683 A NL 7011683A NL 7011683 A NL7011683 A NL 7011683A
Authority
NL
Netherlands
Application number
NL7011683A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NL7011683A priority Critical patent/NL7011683A/xx
Priority to ZA714729A priority patent/ZA714729B/xx
Priority to US00164830A priority patent/US3804898A/en
Priority to AU31531/71A priority patent/AU3153171A/en
Priority to CA119,051A priority patent/CA971970A/en
Priority to FR7128715A priority patent/FR2102106A1/fr
Priority to HUOA476A priority patent/HU162459B/hu
Priority to BE771055A priority patent/BE771055A/nl
Priority to DE19712139526 priority patent/DE2139526A1/de
Publication of NL7011683A publication Critical patent/NL7011683A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06—One of the condensed rings being a six-membered aromatic ring the other ring being four-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NL7011683A 1970-08-07 1970-08-07 NL7011683A (e)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NL7011683A NL7011683A (e) 1970-08-07 1970-08-07
ZA714729A ZA714729B (en) 1970-08-07 1971-07-16 Novel benzcyclobutene derivatives
US00164830A US3804898A (en) 1970-08-07 1971-07-21 Novel benzcyclobutene derivatives
AU31531/71A AU3153171A (en) 1970-08-07 1971-07-22 Novel benzcyclobutene derivatives
CA119,051A CA971970A (en) 1970-08-07 1971-07-26 Benzcyclobutene derivatives
FR7128715A FR2102106A1 (fr) 1970-08-07 1971-08-05 Nouveaux derives du benzocyclobutene
HUOA476A HU162459B (e) 1970-08-07 1971-08-06
BE771055A BE771055A (nl) 1970-08-07 1971-08-06 Werkwijze ter bereiding van nieuwe benzcyclobuteenderivaten
DE19712139526 DE2139526A1 (e) 1970-08-07 1971-08-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7011683A NL7011683A (e) 1970-08-07 1970-08-07

Publications (1)

Publication Number Publication Date
NL7011683A true NL7011683A (e) 1972-02-09

Family

ID=19810731

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7011683A NL7011683A (e) 1970-08-07 1970-08-07

Country Status (9)

Country Link
US (1) US3804898A (e)
AU (1) AU3153171A (e)
BE (1) BE771055A (e)
CA (1) CA971970A (e)
DE (1) DE2139526A1 (e)
FR (1) FR2102106A1 (e)
HU (1) HU162459B (e)
NL (1) NL7011683A (e)
ZA (1) ZA714729B (e)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013682A (en) * 1973-08-03 1977-03-22 Akzona Incorporated N-hydroxy-amidine compounds
US4101675A (en) * 1973-11-09 1978-07-18 Akzona Incorporated Novel 2,6-di-substituted phenyl-aminoquanidine containing compositions and methods of using same and pharmaceutical compositions containing the same and therapeutic method
NL7315350A (nl) * 1973-11-09 1975-05-13 Akzo Nv Nieuwe aminoguanidine verbindingen.
NL7407469A (nl) * 1974-06-01 1975-12-03 Akzo Nv Nieuwe amidinohydrazonverbindingen.
US5478863A (en) * 1986-07-10 1995-12-26 State Of Oregon, Oregon Health Sciences University Of Oregon Substituted guanidines having high binding to the sigma receptor and the use thereof
US5312840A (en) * 1986-07-10 1994-05-17 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education Substituted guanidines having high binding to the sigma receptor and the use thereof
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5336689A (en) * 1990-03-02 1994-08-09 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
DK0517852T3 (da) 1990-03-02 2002-10-07 Oregon State Tri- og tetrasubstituerede guanidinerog disses anvendelse som excitatoriske aminosyre-antagonister
US5574070A (en) * 1990-05-25 1996-11-12 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Substituted guanidines having high binding to the sigma receptor and the use thereof
JPH06506455A (ja) * 1991-02-08 1994-07-21 ケンブリッジ・ニューロサイエンス・インコーポレイテッド 神経伝達物質放出調節剤としてのグアニジン置換体及びその誘導体ならびに神経伝達物質放出遮断物質を同定するための新規な方法
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
EP0705100B1 (en) * 1993-05-27 2003-07-30 CeNes Limited Therapeutic substituted guanidines
EP0739200A4 (en) * 1993-11-23 1997-12-17 Cambridge Neuroscience Inc SUBSTITUTED GUANIDINES FOR THERAPEUTIC USE
US5877218A (en) 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
EP0738149B1 (en) * 1994-01-10 2006-11-29 Teva Pharmaceutical Industries, Ltd. 1-aminoindan derivatives and compositions thereof
CA2182302A1 (en) 1994-02-03 1995-08-10 Stanley M. Goldin Therapeutic guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6025355A (en) * 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) * 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
DE69732984T2 (de) 1996-12-18 2006-02-16 Teva Pharmaceutical Industries Ltd. Aminoindanderivate
US6737547B1 (en) 1998-12-31 2004-05-18 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using N-acyl-1H-aminoindenes
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
US20070135518A1 (en) * 2005-12-09 2007-06-14 Marta Weinstock-Rosin Use of low-dose ladostigil for neuroprotection
BRPI0620659A2 (pt) * 2005-12-09 2017-10-31 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd método para a prevenção do aparecimento de sintomas de uma doença neurodegenerativa em um indivíduo predisposto à doença neurodegenerativa, método de redução de stress oxidante no cérebro de um indivíduo afligido com stress oxidante, método de tratamento de um indivíduo afligido com a degeneração cognitiva suave e composição farmacêutica
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof

Also Published As

Publication number Publication date
FR2102106A1 (fr) 1972-04-07
BE771055A (nl) 1971-12-16
ZA714729B (en) 1972-04-26
DE2139526A1 (e) 1972-03-09
US3804898A (en) 1974-04-16
AU3153171A (en) 1973-01-25
HU162459B (e) 1973-02-28
CA971970A (en) 1975-07-29

Similar Documents

Publication Publication Date Title
HU162459B (e)
AU1473870A (e)
AU2044470A (e)
AU2085370A (e)
AU1326870A (e)
AU1336970A (e)
AU1716970A (e)
AU1833270A (e)
AU2017870A (e)
AU1832970A (e)
AU1918570A (e)
AU1328670A (e)
AU1343870A (e)
AU1581370A (e)
AU1086670A (e)
AU1591370A (e)
AU2144270A (e)
AU2131570A (e)
AU2130770A (e)
AU2130570A (e)
AU2119370A (e)
AU2115870A (e)
AU2112570A (e)
AU1603270A (e)
AU2061170A (e)